Search results for:

First name: Last name:
Country:
Keywords: Search in:
Year:
Format:
6522 match(es)

2011 Hyderabad (India)

Presentations

September 3

R1 - Pharmacovigilance and Medicines Information to Enhance Patient Safety

September 5

A1 - A primer on quality and safety

B1 - Environment and pharmaceuticals

C1 - WHO Guidelines on multisource drugs and interchangeability

C2 - Biosimilars

D1 - Forum for innovators in pharmacy practice (part 1)

D2 - Forum for innovators in pharmacy practice (part 2)

D3 - Clinical Biology in India health care system: Organisation and contribution

F1 - Careers and leadership in pharmacy and education

F2 - Generic and patient experience

F9 - FIP Member organisations presenting national updates (part 1)

FIP Host Madsen Award Lecture

J1 - Building practitioner's skills

J2 - Your career in Industrial Pharmacy - From drug development to drug distribution

J3 - Regulatory and legislative changes from across the world

J4 - Pharmacogenomics in oncology

J5 - Careering toward advanced levels of practice

J6 - Communicating basic medicines information to patients

September 6

A2 - Learning from errors and monitoring safety

C3 - Clinical research

C4 - Paradigm shift in research and development

D10 - Recent advances and challenges in the safe preparation of cytotoxic agents

D4 - Current Issues Session - Vulnerable populations

D5 - Solving tableting problems

D6 - Basel statements in developing and developed countries

D7 - A glimpse of Community Pharmacy in 2020

D9 - Medication safety and risk management

F10 - FIP Member organisations presenting national updates (part 2)

F12 - FIP Symposium on counterfeit medicines

F3 – FIP/WHO Symposium on Engaging Pharmacists in Tuberculosis care and control

F4 - Report of the WG on Maternal, Newborn and Children Health

F5 - Outcomes of the Pharmacy Education Taskforce: a report, review and reflection

J7 - Trends in Community Pharmacy - Debating the future of the profession: Forum for policy makers

J8 - Competition - Short Oral Communications of the FIP Industrial Pharmacy Section

September 7

A3 - Building a safer service: Techniques and tools to improve quality and safety

A4 - Paying pharmacists for patient outcomes

C5 - Pharmaceutical manufacturing

C6 - Standardization of herbal products

D11 - Practitioners' day (part 1)

D12 - Practitioners' day (part 2)

D13 - Innovations to improve teaching and learning

D14 - Quality and safety in pharmacologistics

D23 - Communication and Control in an Operational Setting

F11 - FIP Member organisations presenting national updates (part 3)

F6 - Mapping a new vision - Translating ideas into practice

J10 - Building a 'Toolbox' for practitioner development and support

J12 - Pharmaceuticals in the Environment

J9 - Pediatric medicines - Challenges and opportunities

September 8

C7 - Dissolution: The pivotal tool for developing quality drugs

D15 - Pharmacists and mass communication - A job that needs to be done continuously

D16 - Short oral communications of the FIP Social and Administrative Pharmacy Section

D17 - Good Manufacturing Practices - Expectations for the coming decade (part I)

D18 - Good Manufacturing Practices - Expectations for the coming decade (part II)

D19 - Ask your pharmacist Day (part 1) - Immunizations in community pharmacy - Ask your pharmacist!

D20 - Ask your pharmacist Day (part 2) - Healthy travelling? - Ask your pharmacist!

D21 - Short oral communications of the Academic Pharmacy Section

F7 - Symposium on the History of Pharmacy

J13 - Developing young academics through networking and mentoring

J14 - Pharmacovigilance

Poster and Presentations

Academic Pharmacy

Community Pharmacy - Collaborative Care

Community Pharmacy - Good Pharmacy Practice

Community Pharmacy - Primary Care Activities

Community Pharmacy - Quality and Safety

Industrial Pharmacy

Pharmacy Information

Social and Administrative Pharmacy

Poster

Academic Pharmacy

Bioavailability/Bioequivalence

Biopharmaceutics Classification System / Biowaiver

Clinical Biology

Community Pharmacy - Collaborative Care

Community Pharmacy - Good Pharmacy Practice

Community Pharmacy - Other

Community Pharmacy - Primary Care Activities

Community Pharmacy - Quality and Safety

Dissolution / Drug Release

Hospital Pharmacy

Individualised Medicine

Industrial Pharmacy

Laboratories and Medicines Control Services

Medicinal Chemistry

Natural Products

Nuclear Pharmacy

Pharmaceutical Biotechnology

Pharmacoeconomics/Pharmacoepidemiology

Pharmacy Information

Social and Administrative Pharmacy

Biography

Press

2010 Lisbon (Portugal)

Presentations

August 28

R1 - How to develop Academic capacity

R2 - Resources to support medicines information services

R3 - Forum for innovators

August 29

R4 - Pharmacy in Portugal

R5 - Learning to teach workshop

August 30

A1 - Pharmacy as a Profession: Today and Tomorrow

B1 - Adherence to treatment

C2 - Why is Dissolution Testing still needed?

C3 - Evolution of pharmaceutical care by molecular diagnosis at genome and post-genome era

D1 - Contemporary challenges for the Pharmacy Profession

D2 - Preparing the pharmacy for the new business model

E1 - Short oral communications from the Academic Pharmacy Section

E2 - Developing an Academic career

E3 - Clinical Biology - an educational challenge

F1 - Dealing with special patients workshop

G1 - Pharmacy building bridges

G2 - Regulatory dialogue in building sustainable environment for pharma innovation

G3 - Patient packs versus dispensing from bulk - worldwide experience of individualised packaging of medicines for patients

August 31

A2 - Medicines that Changed the World: past, present and future

B2 - Pharmacogenetics: pharmacists get ready!

C4 - Gaps in Drug Development and strategies to avoid the risk and increase drug safety

C5 - Approving Generics without human bioequivalence studies

D3 - Forum for policy makers - Trends in community pharmacy

D4 - Implementation of the Basel Statements - Country and Regional Action: the evidence

D5 - Leadership in Practice

E4 - 5th Global consultation on Pharmacy Education

F2 - Public Health Pharmacy - An unveiling paradigm of quintessential Pharmaceutical Care, Practice and therapeutic outcomes

G4 - Using Clinical Microbiology Data to Improve Antiinfective Utilization at bedside

G5 - Social, Political and Biological Aspects of Anti Microbial Resistance: an integrated approach

G6 - Using Pharmacy Technology to improve patient outcomes and safety

H1 - The Best industrial pharmacy contributions of 2010 - Short Oral Communications

H2 - From Prescription-only medicine to Over-the-counter. Could the pharmacy-only medicine category be the best alternative? Perspectives from different stakeholders

September 1

A3 - The Journey Towards Better Outcomes

A4 - Getting from Here to There

C6 - Nanomedicine: integrating nanotechnology in health care

C7 - Advanced therapies: pharmaceuticals’ new dimension?

D6 - Practitioners’ Day (part 1/2)

D7 - Practitioners’ Day (part 2/2)

E5 - Engaging learners in Continuing Professional Development workshop

F3 - Influenza A (H1N1) pandemic: facing the global challenges

F4 - Optimising Outcomes in an Operational Environment

G7 - Combating counterfeit medicines (part 1)

G8 - Combating counterfeit medicines (part 2)

H6 - Pharmacists: an untapped potential in Tuberculosis control

September 2

C8 - The need for new antibiotics combating resistant bacteria

D8 - Pharmacists serving patients - Short Oral Communications

E6 - Competence in pharmacies - the roles of internships and Life Long Learning (part 1/2)

G10 - Current issues in medicine and healthcare information - Short Oral Communications

G9 - Balancing safety management and sustainable innovation: What can Pharma learn from other industries?

H4 - Working Group History of Pharmacy (part 1)

H5 - Working Group History of Pharmacy (part 2)

H7 - Latest updates from FIP member organisations (part 1)

H8 - Latest updates from FIP member organisations (part 2)

Poster and Presentations

Academic Pharmacy

Administrative Pharmacy

Community Pharmacy - Collaboration

Community Pharmacy - Implementation

Community Pharmacy - Strategies

Industrial Pharmacy

Pharmacy Information

Poster

Academic Pharmacy

Administrative Pharmacy

Bioavailability/Bioequivalence

Clinical Biology

Community Pharmacy - Collaboration

Community Pharmacy - Competence

Community Pharmacy - Implementation

Community Pharmacy - other

Community Pharmacy - Pharmacy facilities

Community Pharmacy - Strategies

Dissolution/In Vitro Release Performance Testing

Hospital Pharmacy

Individualised Medicine

Industrial Pharmacy

Laboratory and Medicines Control Services

Medicinal Chemistry

Military & Emergency Pharmacy

Natural Products

Nuclear Pharmacy

Pharmaceutical Biotechnology

Pharmacoepidemiology/Pharmacoeconomics

Pharmacy Information

Biography

2009 Istanbul (Turkey)

Presentations

September 3

R1 - Forum for innovators : Managing change - Quality work in pharmacies

September 4

R3 - Current trends in community pharmacy in Turkey

September 5

A1 - The World is Sick: Who Owns the Problem?

B1 - Translational Science

C1 - Nanomedicine

C2 - Individualisation of Drug Therapy and Ethical Concerns

D1 - Conducting and Using national and international surveys to advance hospital pharmacy

D2 - Sustainable flow of pharmaceuticals

E1 - Current issues in continuing professional development

E10 - Joint FIP-WHO session: pharmacy workforce development – challenges and strategies

F1 - Cultural and Health beliefs behind the medicine use

F2 - Can Medicine Management improve the use of medicines?

G1 - The 10 best industrial pharmacy contributions of 2009

G2 - Educating patients about how to make use of web-based information sources

September 6

A2 - The Gap Between What We Know and What We Do

C3 - New Strategies in Modern Medicinal Chemistry

C4 - Contribution of pharmacovigilance to public health

C5 - Quality, Safety and Efficacy of Natural Products

D3 - Forum for Policy Makers - Trends in community pharmacy

D3 - Forum for policy makers - Trends in community pharmacy

D4 - Strategies of pharmacists to adapt to an increased competition

E3 - 4th global pharmacy education taskforce consultation

F3 - Sharing information with patients to enhance treatment outcomes

F4 - Combating Antimicrobial resistance for patient safety

G3 - Product quality of biotech drug products: possibilities and limitations for medicinal control

G4 - Pharmaceutical Inspections

H4 - Horizon scanning in the developing world professionalism at the pharmacy: How do we ensure that, independantly of ownership?

H5 - Joint session FIP – IFCC: Clinical Biology in Turkey and Food Allergy

September 7

A3 - What has been Achieved in Improving Patient Outcomes?

A4 - Assuring Better Patient Outcomes

C6 - Understanding the Dissolution Testing and IVIVC

C7 - Environment and Pharmaceuticals

C9 - The future of Pharmaceutical Sciences by 2020

D5 - The practitioners' Day (part 1)

D6 - The practitioners' Day (part 2)

D9 - Conclusions from the 19 May 2009 European Court judgment on pharmacy ownership within the EU

E5 - Distance learning

E6 - Pharmaceutical Education - the use of virtual reality for teaching industrial practice

F5 - Pharmacogenomics - fundamental basis and use in therapeutics

G5 - The challenging world of today’s clinical development

G6 - Current issues on drug and healthcare information

H6 - Symposium on History of Pharmacy (part 1)

H7 - Symposium on History of Pharmacy (part 2)

H8 - Being ready: Knowing the latest Emergency Pharmacy Innovation

September 8

A5 - Being ready: Preparation to ensure positive patient outcomes in a mass casualty situation

A6 - Pharmacists working for improved patient outcomes – short oral communications

C8 - Nuclear Pharmacy (Round Table)

D7 - Public Health role of pharmacists

D8 - The Basel Statements on the Future of Hospital Pharmacy - local experiences.

E7 - AcPS Short Oral Presentations

E8 - How to get your research published?

F6 - Pharmacy practice in the era of pharmacogenomics - Are we ready for the prime time?

G10 - Current pharmaceutical GMP concepts and trends (part 2)

G7 - Compounding (part 1)

G8 - Compounding (part 2)

G9 - Current pharmaceutical GMP concepts and trends (part 1)

Poster and Presentations

Academic Pharmacy

Administrative Pharmacy

Community Pharmacy: New services e-world

Community Pharmacy: Other

Community Pharmacy: Public health

Community Pharmacy: Quality

Industrial Pharmacy

Pharmacy Information

Poster

Academic Pharmacy

Administrative Pharmacy

Bioavailability and Bioequivalence

Biopharmaceutics Classification System

Clinical Biology

Community Pharmacy: Compounding

Community Pharmacy: New services e-world

Community Pharmacy: Other

Community Pharmacy: Public health

Community Pharmacy: Quality

Dissolution/In Vitro Release Performance Testing

Hospital Pharmacy

Individualised Medicine

Industrial Pharmacy

Laboratory and Medicines Control Services

Medicinal Chemistry

Miscellaneous

Natural Substances

Pharmaceutical Biotechnology

Pharmacoepidemiology/Pharmacoeconomics

Pharmacy Information

Biography

2008 Basel (Switzerland)

Presentations

August 29

R1 - IPS Workshop on PAT (Part 1)

August 30

R1 - IPS Workshop on PAT (Part 2)

R4 - Forum for innovators in pharmacy practice

R5 - Global conference on the future of hospital pharmacy

August 31

R6 - Global perspectives of pharmacy changes in Europe

September 1

G1 - Can technology help to reach better adherence to medications?

G2 - Pharmacy management and dispensing to HIV-patients in developing countries

G3 - Making Paediatric Medicines work

G4 - Advocating for pharmacy

G5 - The role of pharmacists in primary health care in the developing world

G6 - ICT Showcase: IT Solutions in Pharmacy Practice

G7 - Report on the work of the FIP Fora

G8 - Clinical biology in European Countries

P1 - Health Care Systems in Change

PS1 - Combating Counterfeit Medicines in Africa

S1 - Dissolution Testing: A pivotal tool for development and quality of drugs

S2 - Vaccines

September 2

G10 - How to promote lifelong learning through curriculum design?

G11 - Professional and regulatory issues of Patient Safety

G12 - Cooperation between clinical biologists, pharmacists and physicians for the benefit of the patients

G13 - Community Pharmacy - Business or healthcare?

G14 - Medicines information for patients

G16 - State-of-the art production of biotech products

G9 - Forum for policy makers in pharmacy practice

Joint Symposium of WG History of Pharmacy and ISHP (Part 1)

Joint Symposium of WG History of Pharmacy and ISHP (Part 2)

P2 - Pharmacy Practice: Present and Future

PS2 - BPP/BPS Symposium on individualised/personalised medicines

S3 - Natural Products as therapeutic modulators

S4 - Targeted drug delivery: From Concept to Clinical reality

S8 - Short Oral and Poster Presentations

September 3

Administrative Pharmacy Section Short oral presentations

G17 - Practitioners' Day (Part 1)

G18 - Current issues on drug and healthcare information

G19 - Clinical hospital pharmacy practice - from dreams to reality and beyond

G20 - Short oral communications on Pharmaceutical Manufacturing and Drug Delivery Technologies

G21 - Practitioners' Day (Part 2)

G22 - Patient Safety, Risk Assessment and Risk Management

G23 - Patients in control of their records

G24 - Meeting the pharmacy education needs for a career in pharmaceutical industry or research

P3 - Patients as Partners

P4 - Workforce, Competence and Education Reform

S5 - Biosimilars (Part I): Dream to reality

S5 - Biosimilars (part II): From science to practice

September 4

G25 - Pharmacoeconomics for practitioners: An opportunity to enhance your practice (Part 1)

G26 - Medication reviews - Collaboration between pharmacists, physicians and patients

G27 - Developing higher level practice- visions, experiences and practice

G28 - Healthcare to Logistics, Pharmacy Practice in the Emergency Arena (Part 1)

G29 - Pharmacoeconomics for practitioners: an opportunity to enhance your practice (part 2)

G30 - Short Oral Presentations of the Academic Pharmacy Section

G31 - Healthcare to Logistics, Pharmacy Practice in the Emergency Arena (Part 2)

S6 - Implementation of Quality by Design and Risk Management- overcoming the practical hurdles

S7 - Translational Science: Research into clinical practice

Poster and Presentations

Community Pharmacy: IT-solutions in pharmacy practice

Community Pharmacy: Medication review and other new pharmacy services

Community Pharmacy: New ways of collaboration

Community Pharmacy: Quality assurance in community pharmacy

Community Pharmacy: The role of the pharmacist in public health

Pharmacoepidemiology/Pharmacoeconomics

Pharmacy Information

Poster

Academic Pharmacy

Administrative Pharmacy

Bioavailability and Bioequivalence

Biopharmaceutics Classification System

Clinical Biology

Community Pharmacy: IT-solutions in pharmacy practice

Community Pharmacy: Medication review and other new pharmacy services

Community Pharmacy: New ways of collaboration

Community Pharmacy: Other

Community Pharmacy: Quality assurance in community pharmacy

Community Pharmacy: The role of the pharmacist in public health

Dissolution/In Vitro Release Performance Testing

History of Pharmacy

Hospital Pharmacy

Individualized Medicine

Industrial Pharmacy

Laboratory and Medicines Control Services

Medicinal Chemistry

Military and Emergency Pharmacy

Miscellaneous

Natural Substances

Nuclear/Radiologic Pharmacy

Pharmaceutical Biotechnology

Pharmacoepidemiology/Pharmacoeconomics

Pharmacy Information

Biography

2007 Beijing (China)

Presentations

September 1

R4 - Forum for innovators in pharmacy practice: Pharmacist advice at the counter - Implementation of Best Practice Standards

September 2

R4 - Forum for innovators in pharmacy practice: Pharmacist advice at the counter - Implementation of Best Practice Standards

September 3

BPP/BPS Joint Symposium (part 1)

G1 - Life long learning and continuing professional development: We have all heard the theory, what is the evidence?

G10 - Financing the healthcare

G17 - Pharmaceuticals and the environment

G18 - How to guarantee the best therapeutic outcome of a pharmaceutical product - The influence of a life cycle

G2 - Experiential learning - Bridging classroom education and pharmacy practice

G25 - Antimicrobial drug resistance - The role of the pharmacy profession in tackling this emerging global health problem

G26 - Risk communication in patient safety: To what extent can pictograms help in labeling?

G33 - Workshop: Nuclear/radiologic pharmacy

G34 - Clinical biology in South East Asia

G9 - FIP/IPSF students’ day: Social dimensions of developing the pharmacy profession

P1 - Personal, cultural and social belief systems and the use of medicines

S1 - Dissolution testing: A pivotal tool for development and quality of drugs

S2 - Pharmacoepidemiology: (a) hepatitis model & (b) antibiotic resistance

Working Group History of Pharmacy

September 4

BPP/BPS Joint Symposium (part 2)

Curbing the tobacco pandemic - The role of the pharmacist

G11 - Trends in community pharmacy – Debating the future of the profession: Forum for policy makers in pharmacy practice

G19 - Clinical trials in Asia

G27 - Customer relationships (part 1)

G28 - Customer relationships (part 2)

G3 - Evidence based practice and complementary medicines: Teaching and learning by example

G35 - Evolution of practices in clinical biology

G36 - Nanotechnology: From science to industrial practice

G4 - Is there enough evidence for the value of pharmacists?

P2 - Regulatory, manufacturing, supply-chain and quality standards issues

S3 - Improving bioavailability/bioequivalence

S4 - Biotechnology

September 5

G13 - Practitioners' Day CPS: Forum I (Part 1)

G14 - Practitioners' Day CPS: Forum I (Part 2)

G21 - Practitioners' Day CPS: Forum II (Part 1)

G22 - Practitioners' Day CPS: Forum II (Part 2)

G23 - WHO/FIP workshop: Herbal medicines: Education and training of pharmacy practitioners

G29 - Medication reviews: From medication counselling towards service delivery

G30 - Good versus bad drug information in the public domain - can you spot the difference?

G37 - Manufacturing and good manufacturing practice IPS (part 1)

G38 - Manufacturing and good manufacturing practice IPS (part 2)

G5 - Short oral presentations FIP Academic Pharmacy Section

G6 - Strengthening the responsible self care of patients

P3 - Technical, scientific and evidence-based information resources about medicines

P4 - Future issues with conventional, and complementary & alternative medicines

S5 - Quality control for natural products

S6 - Research in natural products

September 6

G15 - Continuing education programme: From research to daily practice - Implementing family pharmacy

G24 - Good Manufacturing Practice (GMP) & Good Clinical Practice (GCP)

G31 - The use of informatics to improve medication safety

G32 - Current issues on drug and healthcare information

G39 - Rationalising medication management for emergency response

G7 - The Asian drug market – current topics and challenges

G8 - The challenges of diabetes in Asia

S7 - Impact of individualised medicine in pharmaceutical care

S8 - From knowledge to controlling: Medicinal chemistry based on chemical biology

Poster and Presentations

Academic Pharmacy Section

CPS 1. Innovative ways of collaboration

CPS 3. Counterfeit medicines

CPS 4. The role of the pharmacist in public health

CPS 5. Other

Industrial Pharmacy Section

Pharmacy Information Section

Poster

Academic Pharmacy Section

Administrative Pharmacy Section

Clinical Biology Section

CPS 1. Innovative ways of collaboration

CPS 2. Experiences with patient profiles

CPS 3. Counterfeit medicines

CPS 4. The role of the pharmacist in public health

CPS 5. Other

Hospital Pharmacy Section

Industrial Pharmacy Section

Laboratories and Medicines Control Services Section

Military and Emergency Pharmacy Section

Miscellaneous

Pharmacy Information Section

SIG Bioavailability/Bioequivalence

SIG Biopharmaceutics Classification System

SIG Dissolution/In Vitro Release Performance Testing

SIG Individualised Medicine

SIG Natural Substances

SIG Nuclear/Radiologic Pharmacy

SIG Pharmaceutical Biotechnology

SIG Pharmacoeconomics/Pharmacoepidemiology

Biography

2006 Salvadore (Brazil)

Presentations

August 26

R2 - A Risky Journey? Patient Safety from Home to Hospital and Back

August 27

R2 - A Risky Journey? Patient Safety from Home to Hospital and Back

August 28

G1 - Learning for Practice

G19 - Industrial Pharmacy Education and practice

G2 - Managing Change in Pharmacy Practice

G4 - Reaccreditation: Is a First Degree enough for Life?

G5 - FIP & IPSF Students' Day: Community Pharmacy - Advancing Patient Care

G7 - Current issues on drug and healthcare information

P1 - Innovations in Patient Treatment

S1 - Nanotechnology

S2 - Bioequivalence and BCS

S8 - SIG: Quality Issues

Working Group History of Pharmacy - Short Oral Presentations

August 29

F2 - Infectious diseases - diarrhea

G10 - International regulatory issues for innovative medicines

G11 - Pricing Policy in a Global Market

G12 - Steering committee meeting: Building customer relationships

G13 - Pharmacists as Advocates of Public Health

G8 - The role of the pharmacist in public health

G9 - Web-Originated Consumer Medicines Information – Where Are We Now?

P2 - Innovative Healthcare Delivery

PS1 - Combating Counterfeiting (part 1)

S3 - Biotechnology

S4 - Natural Products research and development

August 30

G14 - Biosimilars: the effect on practice

G15 - Counselling, Concordance and Communication: Innovative Education for Pharmacists

G16 - Short oral presentations of the Community Pharmacy Section

G17 - Training Hospital Pharmacists for the Future

G18 - Innovations in Pharmacy Practice

G6 - Country Specific Approaches in Pharmacoepidemiology and Pharmacoeconomics

P3 - Using Innovations to Improve Patient Safety

P4 - Innovations in Learning and Education

PS2 - Combating Counterfeiting (part 2)

S5 - Quality Assessment of Biotechnological Products

S6 - Nuclear Pharmacy Practice and Science Workshop

Seminar on Good Pharmacy Practice

August 31

G20 - Integration of Electronic Patient Health Record Systems into the Pharmacy

G21 - YPG Educational Forum: Emerging trends in Pharmacy

G22 - Antimicrobial Drug Resistance

G23 - Short oral presentations of the Academic Pharmacy Section

G24 - Patient Care in the 21st Century Marching Forward: Innovations, Experiences and Outcomes

S7 - Pharmacovigilance

Poster and Presentations

Academic Pharmacy

Community Pharmacy

History of Pharmacy

Industrial Pharmacy

Pharmacy Information

Poster

Academic Pharmacy

Administrative Pharmacy

Clinical Biology

Community Pharmacy

History of Pharmacy

Hospital Pharmacy

Industrial Pharmacy

Laboratories and Medicines Control Services

Military & Emergency Pharmacy

Pharmacy Information

SIG Bioavailability / Bioequivalence

SIG Individualized Medicines

SIG Natural Substances

SIG Nuclear/Radiologic Pharmacy

SIG Pharmaceutical Biotechnology

SIG Pharmacoeconomics/Pharmacoepidemiology

SIG Quality of Pharmaceuticals

Biography

2005 Cairo (Egypt)

Presentations

September 3

R2 - Compliance, adherence or concordance: Who cares?

September 5

G1 - Educating pharmacists to empower patients

G10 - Supply chain management contracting and shortages

G9 - Information sharing to address counterfeit and substandard medicines

P1 - Access to medicines

P2 - The price of medicines

S1 - Biopharmaceutics and drug development process

September 6

G12 - Public Health: What does it mean to the healthcare professionals?

G13 - Evaluation studies as basis for decision making

G2 - E-learning in Pharmacy Education

G3 - Meeting of the International Forum for Quality Assurance of Pharmacy Education

G6 - Access and Equity: FIP & IPSF Students’ Day

G7 - HIV/AIDS: With improved access to medications, now what? Models to assure adherence and positive outcomes and associated information needs

P3 - Selection, supply and distribution of medicines

S2 - Pharmaceutical biotechnology in the post-genomic era

September 7

Administrative Pharmacy Section - Session Short Oral Presentations

Community Pharmacy Section - Session Short Oral Presentations

G11 - Paying for Medicines Used in Hospitals

G15 - Changing the Professional Status - The Way Forward to Integrated Care

G18 - Patient Counselling Event

G4 - Human Resources in Hospital Pharmacy

G5 - Plugging the Brain Drain: The migration of young pharmacists

P4 - The world wide problem of counterfeit medicines

S3 - Dissolution - Quality

S4 - Chemistry and Good Manufacturing Practice

S5 - Natural Products

September 8

Academic Pharmacy Section - Session Short Oral Presentations

G8 - Access to Medicines

Industrial Pharmacy Careers Day

P5 - Thinking the unthinkable

Pharmacy Information Section - Session Short Oral Presentations

Poster and Presentations

Academic Pharmacy Section

Administrative Pharmacy Section

Community Pharmacy Section

Pharmacy Information Section

Poster

Academic Pharmacy Section

Administrative Pharmacy Section

Clinical Biology Section

Community Pharmacy Section

Hospital Pharmacy Section

Industrial Pharmacy Section

Laboratory and Medicines Control Services Section

Military and Emergency Pharmacy Section

Pharmacy Information Section

SIG - Bioavailability / Bioequivalence

SIG - Individualized Medicines

SIG - Natural Substances

SIG - Nuclear / Radiologic Pharmacy

SIG - Pharmaceutical Biotechnology

SIG - Pharmacoepidemiology/Pharmacoeconomics

SIG - Quality of Pharmaceuticals

Biography

2004 New Orleans (USA)

Presentations

September 6

BPP Symposium 2: The Patient and the Pharmacist in Different Healthcare Systems

Diagnostics: A patient and pharmacist partnership in healthcare (SIG Nuclear/Radiologic Pharmacy)

New Technologies in Hospital Pharmacy (Hospital Pharmacy Section)

Working Group On The History Of Pharmacy Oral Communications

September 7

BPP Special Symposium: Responding to the HIV/AIDS crisis in resource-limited settings

BPP Symposium 3: Patients and Pharmacists Working With New Technologies

BPP/BPS Joint Symposium: Getting Medicines Right for Children

Comparing Healthcare Systems (Administrative Pharmacy Section)

Moving forward drug product Quality (SIG Bioavailability/Bioequivalence)

Post-Marketing innovation in Drug Development (SIG Pharmacoeconomics/Pharmacoepidemiology and Industrial Pharmacy Section)

The value and use of technologies in teaching Pharmacy (Academic Pharmacy Section)

September 8

Advertising drugs to consumers - A public health threat or a source of needed information? (Pharmacy Information Section)

BPP Symposium 4: The Increasingly Knowledgeable Patient

Current Issues in drug and healthcare information (Pharmacy Information Section)

Direct-To-Consumer Advertising (Hospital Pharmacy Section and Industrial Pharmacy Section)

Electronic information exchange between the healthcare sector and the pharmacy (Pharmacy Information Section)

Medicines information for illiterate patients in emergency situations (Military and Emergency Pharmacy Section)

Osteoporosis And Fractures (SIGs Nuclear/Radiologic Pharmacy and Pharmacoeconomics/Pharmacoepidemiology)

September 9

BPP Symposium 5: The changing role of the pharmacist in medicines management

Current Issues in drug and healthcare information (Pharmacy Information Section)

Pharmacogenomics genetic profiling and individualising medicines (SIG Pharmaceutical Biotechnology)

Short Oral Communications Community Pharmacy Section

Poster

Practice - Academic Pharmacy Section

Practice - Administrative Pharmacy Section

Practice - Clinical Biology Section

Practice - Community Pharmacy Section

Practice - Computer Demonstration Session

Practice - Hospital Pharmacy Section

Practice - Industrial Pharmacy Section

Practice - Laboratory and Medicines Control Services Section

Practice - Military & Emergency Pharmacy Section

Practice - Pharmacy Information Section

Science - Bioavailability / Bioequivalence

Science - Nuclear/Radiologic Pharmacy

Science - Pharmaceutical Biotechnology

Science - Pharmacoeconomics/Pharmacoepidemiology

Science - Quality of Pharmaceuticals

Working group on the History of Pharmacy